Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration.

Khanifar AA, Koreishi AF, Izatt JA, Toth CA.

Ophthalmology. 2008 Nov;115(11):1883-90. doi: 10.1016/j.ophtha.2008.04.041. Epub 2008 Aug 22.

2.

Identification of Drusen Characteristics in Age-Related Macular Degeneration by Polarization-Sensitive Optical Coherence Tomography.

Schlanitz FG, Sacu S, Baumann B, Bolz M, Platzer M, Pircher M, Hitzenberger CK, Schmidt-Erfurth U.

Am J Ophthalmol. 2015 Aug;160(2):335-344.e1. doi: 10.1016/j.ajo.2015.05.008. Epub 2015 May 15.

3.

Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography.

Schuman SG, Koreishi AF, Farsiu S, Jung SH, Izatt JA, Toth CA.

Ophthalmology. 2009 Mar;116(3):488-496.e2. doi: 10.1016/j.ophtha.2008.10.006. Epub 2009 Jan 22.

4.

Drusen characteristics revealed by spectral-domain optical coherence tomography and their corresponding fundus autofluorescence appearance in dry age-related macular degeneration.

Landa G, Rosen RB, Pilavas J, Garcia PM.

Ophthalmic Res. 2012;47(2):81-6. doi: 10.1159/000324988. Epub 2011 Jul 13.

PMID:
21757965
5.

Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.

Leuschen JN, Schuman SG, Winter KP, McCall MN, Wong WT, Chew EY, Hwang T, Srivastava S, Sarin N, Clemons T, Harrington M, Toth CA.

Ophthalmology. 2013 Jan;120(1):140-50. doi: 10.1016/j.ophtha.2012.07.004. Epub 2012 Sep 8.

6.

Qualitative spectral OCT/SLO analysis of drusen change in dry age-related macular degeneration patients treated with Copaxone.

Landa G, Rosen RB, Patel A, Lima VC, Tai KW, Perez VR, Aizman A, Garcia PM.

J Ocul Pharmacol Ther. 2011 Feb;27(1):77-82. doi: 10.1089/jop.2010.0109. Epub 2011 Jan 23.

PMID:
21254921
7.

Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration.

Veerappan M, El-Hage-Sleiman AM, Tai V, Chiu SJ, Winter KP, Stinnett SS, Hwang TS, Hubbard GB 3rd, Michelson M, Gunther R, Wong WT, Chew EY, Toth CA; Age-related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study Group.

Ophthalmology. 2016 Dec;123(12):2554-2570. doi: 10.1016/j.ophtha.2016.08.047. Epub 2016 Oct 25.

8.

Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies.

Stopa M, Bower BA, Davies E, Izatt JA, Toth CA.

Retina. 2008 Feb;28(2):298-308. doi: 10.1097/IAE.0b013e3181567798. Erratum in: Retina. 2011 Jun;31(6):1236.

PMID:
18301035
9.

Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration.

Yi K, Mujat M, Park BH, Sun W, Miller JW, Seddon JM, Young LH, de Boer JF, Chen TC.

Br J Ophthalmol. 2009 Feb;93(2):176-81. doi: 10.1136/bjo.2008.137356. Epub 2008 Aug 12.

10.

Automated assessment of drusen using three-dimensional spectral-domain optical coherence tomography.

Iwama D, Hangai M, Ooto S, Sakamoto A, Nakanishi H, Fujimura T, Domalpally A, Danis RP, Yoshimura N.

Invest Ophthalmol Vis Sci. 2012 Mar 21;53(3):1576-83. doi: 10.1167/iovs.11-8103.

PMID:
22297491
11.

Early deterioration in ellipsoid zone in eyes with non-neovascular age-related macular degeneration.

Toprak I, Yaylalı V, Yildirim C.

Int Ophthalmol. 2017 Aug;37(4):801-806. doi: 10.1007/s10792-016-0331-3. Epub 2016 Sep 3.

PMID:
27591785
12.

Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration.

Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH.

Ophthalmology. 2014 Dec;121(12):2415-22. doi: 10.1016/j.ophtha.2014.06.034. Epub 2014 Aug 8.

PMID:
25109931
13.

Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration.

Gregori G, Wang F, Rosenfeld PJ, Yehoshua Z, Gregori NZ, Lujan BJ, Puliafito CA, Feuer WJ.

Ophthalmology. 2011 Jul;118(7):1373-9. doi: 10.1016/j.ophtha.2010.11.013. Epub 2011 Mar 9.

14.

Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration.

Schmitz-Valckenberg S, Steinberg JS, Fleckenstein M, Visvalingam S, Brinkmann CK, Holz FG.

Ophthalmology. 2010 Jun;117(6):1169-76. doi: 10.1016/j.ophtha.2009.10.044. Epub 2010 Feb 16.

PMID:
20163861
15.

Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye.

Abdelfattah NS, Zhang H, Boyer DS, Rosenfeld PJ, Feuer WJ, Gregori G, Sadda SR.

Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1839-46. doi: 10.1167/iovs.15-18572.

PMID:
27082298
16.

Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration.

Folgar FA, Yuan EL, Sevilla MB, Chiu SJ, Farsiu S, Chew EY, Toth CA; Age Related Eye Disease Study 2 Ancillary Spectral-Domain Optical Coherence Tomography Study Group.

Ophthalmology. 2016 Jan;123(1):39-50.e1. doi: 10.1016/j.ophtha.2015.09.016. Epub 2015 Nov 12.

PMID:
26578448
17.

Appearance of regressing drusen on optical coherence tomography in age-related macular degeneration.

Querques G, Georges A, Ben Moussa N, Sterkers M, Souied EH.

Ophthalmology. 2014 Jan;121(1):173-9. doi: 10.1016/j.ophtha.2013.06.024. Epub 2013 Jul 25.

PMID:
23891523
18.

Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging.

Gregori G, Yehoshua Z, Garcia Filho CA, Sadda SR, Portella Nunes R, Feuer WJ, Rosenfeld PJ.

Invest Ophthalmol Vis Sci. 2014 Oct 21;55(11):7662-8. doi: 10.1167/iovs.14-15273.

19.

Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD.

Folgar FA, Chow JH, Farsiu S, Wong WT, Schuman SG, O'Connell RV, Winter KP, Chew EY, Hwang TS, Srivastava SK, Harrington MW, Clemons TE, Toth CA.

Invest Ophthalmol Vis Sci. 2012 Jul 9;53(8):4626-33. doi: 10.1167/iovs.12-9813.

PMID:
22589439
20.

Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs.

Jain N, Farsiu S, Khanifar AA, Bearelly S, Smith RT, Izatt JA, Toth CA.

Invest Ophthalmol Vis Sci. 2010 Oct;51(10):4875-83. doi: 10.1167/iovs.09-4962. Epub 2010 Apr 14.

Supplemental Content

Support Center